Historically, there was significant concern for notoriety bias (i.e., increased likelihood of case reporting when patients are exposed to a drug with a negative reputation), which was mitigated by studying disproportionality signals
Provider acceptance changes frequently as new partnerships form
This article did not independently review or cite specific clinical studies for the mechanism claims the brand makes
In fact, many healthcare providers suggest that they may be more effective when used together than when used in isolation
less energy), or it may be a result of some of the drugs other side effects, such as nausea, vomiting, or diarrhea
Subjects received a 16 mg afamelanotide subcutaneous implant or placebo every 60 days (Langendonk et al., 2015)